Frontiers in Oncology (Apr 2023)
Corrigendum: SPOCK1 promotes the development of hepatocellular carcinoma
- Lóránd Váncza,
- Katalin Karászi,
- Bálint Péterfia,
- Lilla Turiák,
- Katalin Dezső,
- Anna Sebestyén,
- Andrea Reszegi,
- Gábor Petővári,
- András Kiss,
- Zsuzsanna Schaff,
- Kornélia Baghy,
- Ilona Kovalszky
Affiliations
- Lóránd Váncza
- 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
- Katalin Karászi
- 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
- Bálint Péterfia
- Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, Budapest, Hungary
- Lilla Turiák
- MS Proteomics Research Group, Research Centre for Natural Sciences, EötvösLoránd Research Network, Budapest, Hungary
- Katalin Dezső
- 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
- Anna Sebestyén
- 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
- Andrea Reszegi
- 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
- Gábor Petővári
- 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
- András Kiss
- 2nd Department of Pathology, Semmelweis University, Budapest, Hungary
- Zsuzsanna Schaff
- 2nd Department of Pathology, Semmelweis University, Budapest, Hungary
- Kornélia Baghy
- 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
- Ilona Kovalszky
- 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
- DOI
- https://doi.org/10.3389/fonc.2023.1203745
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords
- hepatocellular cancer (HCC)
- SPOCK1 in the liver
- SPOCK1 and syndecan-1
- SPOCK1 in mitochondrion
- effect of SPOCK1 inhibition and overexpression
